Breaking News Instant updates and real-time market news.

MYOK

MyoKardia

$52.90

-1 (-1.86%)

07:19
07/10/18
07/10
07:19
07/10/18
07:19

MyoKardia initiated with a Buy at BofA/Merrill

BofA/Merrill analyst Tazeen Ahmad initiated MyoKardia with a Buy and $71 price target saying the company focuses on treating cardiovascular diseases and has two clinical assets, mavacamten and MYK-491, that could become the first FDA therapies approved in hypertrophic and dilated cardiomyopathy. Ahmad believes MyoKardia's investment by Sanofi in mavacamten as a de-risking event.

MYOK MyoKardia
$52.90

-1 (-1.86%)

03/09/18
BMOC
03/09/18
NO CHANGE
Target $83
BMOC
Outperform
MyoKardia price target raised to $83 from $65 at BMO Capital
BMO Capital analyst M. Ian Somaiya raised his price target on MyoKardia to $83, saying the company's Phase 2 PIONEER Cohort-B results "significantly de-risked" EXPLORER Phase 3 trial by establishing a "safe and effective dose titration strategy that could allow physicians to individualize dosing of mavacamten to achieve peak VO2 and LVOT benefit". Somaiya keeps his Outperform rating on MyoKardia, adding that his new price target re-calibrates mavacamten's probability of success.
03/09/18
FBCO
03/09/18
NO CHANGE
Target $68
FBCO
Outperform
MyoKardia price target raised to $68 from $60 at Credit Suisse
Credit Suisse analyst Martin Auster raised his price target on MyoKardia to $68 from $60, saying the company's update on its Phase 2 cohort B data for mavacamten for the treatment of obstructive hypertrophic cardiomyopathy was "just as we hoped." Auster views the news as a "meaningful" de-risking step supporting elevated conviction in the Phase 3 EXLORER study and believes the cohort B results should "incrementally increase" investors' long-term confidence in the mavacamten program. Auster, who has an Outperform rating on shares, added that MyoKardia is one of the most "promising" long-term stories in his coverage.
03/12/18
COWN
03/12/18
NO CHANGE
Target $73
COWN
Outperform
MyoKardia price target raised to $73 from $56 at Cowen
Cowen analyst Ritu Baral raised her price target on MyoKardia to $73 from $56 following the presentation of its full data from the PIONEER-HCM Phase 2 trial's low-dose cohort B of mavacamten in oHCM patients. The presentation underscored the efficacy data as well as continued clean safety, said Baral, who reiterated her Outperform rating on MyoKardia shares.
04/13/18
WELS
04/13/18
NO CHANGE
Target $70
WELS
Outperform
MyoKardia price target raised to $70 from $56 at Wells Fargo
Wells Fargo analyst Jim Birchenough raised his price target for MyoKardia to $70 following his firm's non deal roadshow with senior management. The analyst came away with greater confidence in the prospects for Phase 3 success in hypertrophic cardiomyopathy. He reiterates an Outperform rating on MyoKardia shares.

TODAY'S FREE FLY STORIES

SVU

Supervalu

$32.50

0.01 (0.03%)

08:58
10/22/18
10/22
08:58
10/22/18
08:58
Hot Stocks
Breaking Hot Stocks news story on Supervalu »

Supervalu trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UROV

Urovant Sciences

$11.62

-0.63 (-5.14%)

08:58
10/22/18
10/22
08:58
10/22/18
08:58
Initiation
Urovant Sciences initiated  »

Urovant Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STRO

Sutro Biopharma

$14.55

0.03 (0.21%)

08:57
10/22/18
10/22
08:57
10/22/18
08:57
Initiation
Sutro Biopharma initiated  »

Sutro Biopharma initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$58.49

0.06 (0.10%)

08:56
10/22/18
10/22
08:56
10/22/18
08:56
Recommendations
Schlumberger analyst commentary  »

Schlumberger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXS

BancorpSouth

$28.47

-0.72 (-2.47%)

08:55
10/22/18
10/22
08:55
10/22/18
08:55
Recommendations
BancorpSouth analyst commentary  »

BancorpSouth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXS

BancorpSouth

$28.47

-0.72 (-2.47%)

08:55
10/22/18
10/22
08:55
10/22/18
08:55
Recommendations
BancorpSouth analyst commentary  »

BancorpSouth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$219.28

3.3 (1.53%)

, AMD

AMD

$23.66

-2.95 (-11.09%)

08:55
10/22/18
10/22
08:55
10/22/18
08:55
Options
Notable open interest changes for October 22nd »

Friday's total…

AAPL

Apple

$219.28

3.3 (1.53%)

AMD

AMD

$23.66

-2.95 (-11.09%)

PBR

Petrobras

$15.49

0.16 (1.04%)

MU

Micron

$40.44

-0.86 (-2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Dec

SVMK

SurveyMonkey

$12.97

-0.78 (-5.67%)

08:53
10/22/18
10/22
08:53
10/22/18
08:53
Initiation
SurveyMonkey initiated  »

SurveyMonkey initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$47.59

0.19 (0.40%)

08:52
10/22/18
10/22
08:52
10/22/18
08:52
Conference/Events
Oracle to host investor meeting »

Financial Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 14

    Nov

EBAY

eBay

$28.73

-2.83 (-8.97%)

08:51
10/22/18
10/22
08:51
10/22/18
08:51
Technical Analysis
Technical Take: eBay falls, analyst downgrades »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 03

    Mar

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

08:51
10/22/18
10/22
08:51
10/22/18
08:51
Recommendations
AbbVie analyst commentary  »

AbbVie price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

PYPL

PayPal

$84.75

7.25 (9.35%)

08:50
10/22/18
10/22
08:50
10/22/18
08:50
Periodicals
PayPal CFO tells Yahoo Finance no plans to spin off Venmo »

PayPal CFO John Rainey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

IONS

Ionis Pharmaceuticals

$45.21

-1.13 (-2.44%)

, AZN

AstraZeneca

$39.21

0.25 (0.64%)

08:50
10/22/18
10/22
08:50
10/22/18
08:50
Hot Stocks
Ionis Pharmaceuticals presents Phase 1b/2 data of danvatirsen »

Ionis Pharmaceuticals…

IONS

Ionis Pharmaceuticals

$45.21

-1.13 (-2.44%)

AZN

AstraZeneca

$39.21

0.25 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

AEE

Ameren

$66.06

1.16 (1.79%)

08:49
10/22/18
10/22
08:49
10/22/18
08:49
Hot Stocks
Ameren Missouri to acquire 157-megawatt wind facility in northwest Missouri »

Ameren Missouri, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 11

    Nov

SALT

Scorpio Bulkers

$6.32

0.07 (1.12%)

08:47
10/22/18
10/22
08:47
10/22/18
08:47
Earnings
Scorpio Bulkers reports Q3 EPS (1c), consensus 3c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AAPL

Apple

$219.28

3.3 (1.53%)

08:47
10/22/18
10/22
08:47
10/22/18
08:47
Recommendations
Apple analyst commentary  »

Apple' advertising…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$40.44

-0.86 (-2.08%)

08:46
10/22/18
10/22
08:46
10/22/18
08:46
Initiation
Micron initiated  »

Micron initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJI

South Jersey Industries

$35.20

0.15 (0.43%)

08:46
10/22/18
10/22
08:46
10/22/18
08:46
Conference/Events
South Jersey Industries to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTEA

DavidsTea

$2.60

-0.11 (-4.06%)

, CRMD

CorMedix

$1.24

-0.37 (-22.98%)

08:45
10/22/18
10/22
08:45
10/22/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

DTEA

DavidsTea

$2.60

-0.11 (-4.06%)

CRMD

CorMedix

$1.24

-0.37 (-22.98%)

NBEV

New Age Beverages

$5.83

-0.73 (-11.13%)

CWH

Camping World

$21.37

0.52 (2.49%)

EWJ

iShares MSCI Japan Index Fund

$56.64

0.08 (0.14%)

NEPT

Neptune Wellness

$4.06

-0.26 (-6.02%)

QID

ProShares UltraShort QQQ

$40.24

0.13 (0.32%)

BZUN

Baozun

$39.66

0.21 (0.53%)

IQ

iQIYI

$23.56

-0.9 (-3.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JTPY

JetPay

$2.07

(0.00%)

08:45
10/22/18
10/22
08:45
10/22/18
08:45
Hot Stocks
Breaking Hot Stocks news story on JetPay 

JetPay trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWRS

Global Water Resources

$10.67

0.17 (1.62%)

08:44
10/22/18
10/22
08:44
10/22/18
08:44
Hot Stocks
Global Water Resources receives extension on taxable gain »

Global Water Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

JD

JD.com

$23.00

-0.335 (-1.44%)

08:44
10/22/18
10/22
08:44
10/22/18
08:44
Recommendations
JD.com analyst commentary  »

JD.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$97.15

0.96 (1.00%)

08:43
10/22/18
10/22
08:43
10/22/18
08:43
Recommendations
Walmart analyst commentary  »

Walmart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 15

    Nov

NKE

Nike

$74.19

-1.4 (-1.85%)

08:42
10/22/18
10/22
08:42
10/22/18
08:42
Recommendations
Nike analyst commentary  »

Nike well positioned to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAS

Hasbro

$98.12

-0.36 (-0.37%)

08:41
10/22/18
10/22
08:41
10/22/18
08:41
Technical Analysis
Technical Take: Hasbro drops following earnings miss »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.